X0303 4 2009-06-17 1 0001040666 VNUS MEDICAL TECHNOLOGIES INC VNUS 0001449430 Smeets Guido E C/O VNUS MEDICAL TECHNOLOGIES, INC. 5799 FONTANOSO WAY SAN JOSE CA 95138 0 1 0 0 VP, Clinical Research and CMO Common Stock 2009-06-17 4 A 0 6000 0.00 A 6000 D Common Stock 2009-06-17 4 D 0 6000 29.00 D 0 D Restricted Stock Units 2009-06-17 4 D 0 15000 0.00 D Common Stock 15000 0 D Employee Stock Options (right to buy) 15.72 2009-06-17 4 D 0 50000 0.00 D 2018-11-03 Common Stock 50000 0 D Represents restricted stock units that were awarded to the Reporting Person on February 13, 2009, with the vesting of such restricted stock units subject to the achievement during 2009 of certain performance objectives, as determined by the Compensation Committee of the Board of Directors of VNUS Medical Technologies, Inc. (the "Issuer"). Accordingly, the grant of these restricted stock units was not reported on Form 4. Pursuant to the Agreement and Plan of Merger, dated as of May 7, 2009, by and among Covidien Group S.a.r.l., Covidien Delaware Corp. and the Issuer (the "Merger"), these restricted stock units vested in full and were canceled at the effective time of the Merger in exchange for the right to receive a cash payment of $29.00 for each share into which the vested restricted stock units would otherwise be convertible (without interest and less any applicable withholding taxes). Prior to the effective time of the Merger, the Reporting Person was entitled to receive one (1) share of common stock for each one (1) restricted stock unit. These restricted stock units vested in full and were canceled at the effective time of the Merger in exchange for the right to receive a cash payment of $29.00 for each share into which the vested restricted stock units would otherwise be convertible (without interest and less any applicable withholding taxes). Prior to the effective time of the Merger, the restricted stock units were scheduled to vest in four (4) successive and equal annual installments measured from November 3, 2008. These options were canceled at the effective time of the Merger in exchange for a cash payment of $664,000.00, representing the number of shares of Issuer's common stock underlying such options multiplied by $29.00, less the aggregate exercise price of the options. Prior to the effective time of the Merger, the shares subject to these options were scheduled to vest over four years, with 25% of the shares scheduled to vest on November 3, 2009, and 1/36th of the shares vesting monthly thereafter. /s/ Cindee Van Vleck, Attorney-in-Fact for Guido E. Smeets 2009-06-17